LOCUS BIOSCIENCES Trademark

Trademark Overview


On Friday, January 28, 2022, a trademark application was filed for LOCUS BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the LOCUS BIOSCIENCES trademark a serial number of 97243633. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by Locus Biosciences, Inc.. The LOCUS BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical research, namely, research relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical research, namely, research relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents
locus biosciences

General Information


Serial Number97243633
Word MarkLOCUS BIOSCIENCES
Filing DateFriday, January 28, 2022
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6949794
Registration DateTuesday, January 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and ServicesPharmaceutical research and development; research and development in pharmacology for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders; medical and scientific research; pharmaceutical research in the field of engineered bacteriophage; pharmaceutical research using engineered therapeutics for use in antibacterial drug development; pharmaceutical research, namely, research relating to engineered bacteriophage platforms for improving pharmacological properties; pharmaceutical research, namely, research relating to engineered bacteriophages for use in connection with a wide variety of therapeutic agents

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code042
First Use Anywhere DateMonday, June 8, 2015
First Use In Commerce DateWednesday, January 2, 2019

Trademark Owner History


Party NameLocus Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameLocus Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameLocus Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 21, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, September 21, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 21, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, September 21, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 1, 2022NEW APPLICATION ENTERED IN TRAM